Mapping cognitive dysfunction in relapsing multiple sclerosis with mild disability: A cross-sectional study from

Sruthi S Nair1, Jissa Vinodha Thulaseedharan2, Neenumol Kandagathparambil Rajan2

  • 1Department of Neurology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, Kerala, India.

Abstract

Insights

Cognitive dysfunction is common in early multiple sclerosis (MS). A regionally adapted battery found significant impairment in processing speed, memory, and executive functions in Indian patients with relapsing MS.

Area of Science:

  • Neuroscience
  • Clinical Neurology
  • Psychology

Background:

  • Cognitive dysfunction is an early and common symptom in multiple sclerosis (MS).
  • There is a scarcity of locally adapted neuropsychological data for MS patients in India.
  • Understanding cognitive patterns in diverse populations is crucial for effective MS management.

Purpose of the Study:

  • To identify the pattern of cognitive impairment in Indian patients with relapsing MS (RMS) and mild disability.
  • To utilize a regionally adapted, MS-specific cognitive assessment battery.
  • To compare cognitive performance between persons with MS (pwMS) and healthy controls.

Main Methods:

  • A cohort of 59 pwMS (Expanded Disability Status Scale [EDSS] ≤ 4) and 62 controls were assessed.
  • A battery of 8 neuropsychological tests measuring 11 cognitive functions was employed.
  • Cognitive test scores were compared between groups to identify patterns and associations of impairment.

Main Results:

  • Persons with MS performed significantly worse than controls on 10 out of 11 cognitive measures.
  • The largest effect sizes for impairment were observed in the Paced Auditory Serial Addition Test (PASAT), Symbol Digit Modalities Test (SDMT), verbal fluency (VF), and Trail Making Test-B (TMT-B).
  • Cognitive impairment, defined as performance on two or more abnormal tests, was present in 69.5% of pwMS, with male sex being a significant associated factor.

Conclusions:

  • Nearly two-thirds of persons with MS and mild disability exhibit cognitive abnormalities.
  • The primary domains affected include processing speed, working memory, executive functions, and verbal fluency.
  • These findings highlight the early and widespread nature of cognitive deficits in MS, even with mild disability.

Related Concept Videos

Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
50
Negative and Cognitive Symptoms of Schizophrenia01:30

Negative and Cognitive Symptoms of Schizophrenia

Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
43
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
95
Learning Disabilities01:25

Learning Disabilities

Learning disabilities are cognitive disorders caused by neurological impairments that affect cognitive functions like language and reading, without indicating overall intellectual or developmental challenges. These disabilities differ from global intellectual or developmental disabilities as they are limited to distinct cognitive functions. Common learning disabilities include dysgraphia, dyslexia, and dyscalculia, each of which impacts unique aspects of learning.
Dyslexia
Dyslexia is a...
84